...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Fibrinogen supplementation in cardiac surgery: Where are we now and where are we going?
【24h】

Fibrinogen supplementation in cardiac surgery: Where are we now and where are we going?

机译:心脏外科手术中补充纤维蛋白原:我们现在到哪里去?

获取原文
获取原文并翻译 | 示例

摘要

THIS ISSUE OF THE Journal of Cardiothoracic and Vascular Anesthesia includes 2 interesting contributions focused on fibrinogen levels after coronary artery bypass grafting (CABG) with or without cardiopulmonary bypass (CPB) and on fibrinogen supplementation after complex cardiac surgery (CABG plus valve surgeries or ascending aorta surgeries).2 Momeni et al,1 in an elegant study, including conventional coagulation tests and point-of-care (POC) tests (Multiplate, Verum Diagnostica GmbH, Munich, Germany and ROTEM, Tern International GmbH, Munich, Germany), found that patients undergoing CABG with CPB exhibited significantly lower values of fibrinogen during and after the surgeries compared with patients treated off-pump. In addition, they found that the values of fibrinogen obtained with the FIBTEM test using the ROTEM system correlated well with the conventional Clauss measurement.
机译:《心胸与血管麻醉杂志》的这一期内容包括2篇有趣的著作,着重介绍了有或没有体外循环(CPB)的冠状动脉搭桥术(CABG)后的纤维蛋白原水平以及复杂的心脏手术(CABG加上瓣膜手术或升主动脉)后的纤维蛋白原补充2 Momeni等[1]进行了出色的研究,包括常规的凝血试验和即时护理(POC)试验(Multiplate,德国慕尼黑Verum Diagnostica GmbH和德国慕尼黑市Tern International GmbH的ROTEM),研究发现,接受CPB CABG的患者在手术过程中和手术后的血浆纤维蛋白原值均显着低于非泵送治疗的患者。此外,他们发现使用ROTEM系统通过FIBTEM测试获得的纤维蛋白原值与常规Clauss测量具有很好的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号